I think that the opportunity comes from both reducing overall costs—in 2015 the US health expenditure per capita exceeded $10,000 (according to the CMS) as well as AI, which is fast becoming a &quot;thing&quot;. Molecular surgery, maybe not so much, but it&#x27;s definitely in the books.